The aim of the investigation was to evaluate the efficiency of immunohistochemical methods of diagnosis in complex examination of women with uterine factor infertility.Materials and Methods. A total of 100 patients aged 27 to 42 years were examined, in 59 of the women immunohistochemical markers (ER, PR, Кi-67, CD34, CD56, CD68, CD138, VEGF) were revealed.Results. The study showed significant reduction of CD56-positive cells in all the women, decreased or absent CD138 expression, increased CD34 expression and abnormal VEGF expression. Thus, immunohistochemical markers may serve as additional criteria for evaluation of receptor activity, the adequacy of proliferative and reparative functions of the endometrium prior to pregnancy planning.
Problems associated with the state of health of women in the second half of her life are one of the priorities of modern medicine. The aim of the study was to determine the efficacy and safety of the drug in comparison with placebo in patients of perimenopausal age. Materials and methods. A randomized study was conducted in 40 patients aged 38 to 55 years without chronic somatic and gynecological diseases. The I group included 20 women who underwent therapy with the test drug (7-hydroxymatairesinol-lignan formula), in the second group - 20 women, placebo-controlled (similar dose of placebo). Conclusion. The results of the study showed that 7-hydroxymatairesinol has an effect on peripheral vasodilation, does not cause side effects (drowsiness, weakness, decreased efficiency, does not lead to fluid retention), improves general condition, causes a decrease in foliculostimulant hormone, has a positive effect on breast tissue, increases sexual activity, affects weight loss, improves carbohydrate and lipid metabolism, as well as intracellular enzymatic activity of the liver.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.